|
|
第1回
|
The Drug Discovery Business to Date
|
You learn about a background to the history and business aspects of the pharmaceutical and biotechnology-based industry.
In principle, face-to-face classes are to be conducted.
However, if the class method is changed due to the COVID-19 spread, etc., the change will be notified via the eYUSDL.
|
|
第2回
|
The Drug Discovery Business to Come
|
You learn about the outline of the possible future of the pharmaceutical and biotechnology-based industry.
|
|
第3回
|
How Things Get Done: The Project Team
|
You learn about practical aspects of how projects are conducted in industry.
|
|
第4回
|
Hit Generation
|
You learn about the progression from hit-finding strategies through to compound optimization for in vivo experiments.
|
|
第5回
|
Turning Hits into Drugs, ADMET and PK Properties
|
You learn about the needed features for drugs, including "absorption, distribution, metabolism, excretion, and toxicity."
|
|
第6回
|
Drug R&D and the Organizational Challenges
|
You learn about the characteristics of drug R&D that influence the fundamental economics of this business.
|
|
第7回
|
The Anatomy of a Science-Based Business
|
You learn the followings: What types of firm compete in this segment? How have these changed over time? What kind of strategies have they pursued? and, What capabilities do they have?
|
|
第8回
|
Case Study
|
Case study by using Amgen or Genentech
|
|
第9回
|
The Performance of the Biotech Industry
|
We focus on the financial and operating performance of the biotechnology industry.
|
|
第10回
|
The Monetization of Intellectual Property
|
We argues that three interrelated forces drive the business of biotechnology. They are the transfer of technology from universities to the private sector, capital market, and the market for know-how, respectively.
|
|
第11回
|
Organizational Strategies and Business Models
|
We focus on the strategies and business models that biotech and established pharmaceutical companies might deploy to improve their performance.
|
|
第12回
|
Practical Work
|
It is assigned to read an academic research paper.
|
|
第13回
|
Presentation
|
Everyone has to give a presentation about the paper they read.
|
|
第14回
|
Bio-venture (1)
|
A real bio-venture case is spoken by a visiting lecturer.
|
|
第15回
|
Bio-venture (2)
|
A real bio-venture case is spoken by a visiting lecturer.
|
|
※AL（アクティブ・ラーニング）欄に関する注
・授業全体で、AL（アクティブ・ラーニング）が占める時間の割合を、それぞれの項目ごとに示しています。
・A〜Dのアルファベットは、以下の学修形態を指しています。
【A：グループワーク】、【B：ディスカッション・ディベート】、【C：フィールドワーク（実験・実習、演習を含む）】、【D：プレゼンテーション】
|